Toggle Main Menu Toggle Search

Open Access padlockePrints

V-10153 Vernalis

Lookup NU author(s): Professor Farhad Kamali


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Vernalis is developing V-10153, a recombinant plasminogen activator stimulator, for the potential treatment of thrombotic disorders and cardiovascular disease. By March 2004, a phase II trial in acute myocardial infarction had been completed, and by July 2005, Vernalis intended to initiate a phase II trial in stroke later that same year. © The Thomson Corporation.

Publication metadata

Author(s): Kamali F

Publication type: Review

Publication status: Published

Journal: Current Opinion in Investigational Drugs

Year: 2005

Volume: 6

Issue: 9

Pages: 951-955

ISSN (print): 1472-4472

ISSN (electronic): 2040-3429

PubMed id: 16187695